Image | Li Ganglin, Head of Shenzhen Marketing Center at Fusen Pharmaceuticals

In order to meet the needs of the general public to establish family health protection and consolidate the benchmark brand strength of the pharmaceutical and health industry, on December 4th, Family Doctor Online, in conjunction with the new generation market monitoring organization, held a grand award ceremony in Guangzhou for the "2022-2023 Chinese Family Regular Medicines, Chinese Family Regular Health Foods, Chinese Family Regular Medical Devices and Disinfectants Brands". A total of 300 industry experts, senior executives of well-known pharmaceutical companies, representatives of listed brands, and mainstream media representatives from all over the country attended the event.

The activity selected trustworthy high-quality brands through preliminary review, big data and market research scoring, public voting scores, product publicity, and other processes.

Picture | Award Trophy

Among them, Fusen Shuanghuanglian Oral Liquid has been listed as a cold medicine brand in the "2022-2023 Chinese Household Regular Medicine List" due to its excellent therapeutic effect and wide recognition.

Picture | Award Trophy

It is understood that this list is known as the "wind vane of household regular medicines", jointly organized by Family Doctor Online and the new generation market monitoring agency. Through in-depth investigation and analysis of Chinese consumers' drug preparation needs, cognitive channels, purchasing behavior, purchasing tendencies, medication habits and other data, the aim is to present high-quality medical products in the domestic market to consumers, help improve household regular medicine boxes, and build a healthy defense line for every Chinese family.

Introduction to Fusen Shuanghuanglian Oral Liquid

Fusen Shuanghuanglian Oral Liquid is a leading traditional Chinese medicine product of Fusen Pharmaceuticals. It is a household standard medicine used for wind heat and cold, and is included in the National Essential Medicines Catalogue and the National Medical Insurance Catalogue. Composed of honeysuckle, Scutellaria baicalensis, and Forsythia suspensa, it has the effect of reducing fever, relieving cough, and sore throat. In addition, in clinical practice, in addition to treating wind and cold, Fusen Shuanghuanglian Oral Liquid is also included in guidelines and recommended medication plans for the prevention and treatment of diseases such as influenza, community-acquired pneumonia, Ebola hemorrhagic fever, Middle East respiratory syndrome, chickenpox in children, and acute upper respiratory tract infections in adults/children.

Good medicinal materials make good medicines. In order to control the quality of traditional Chinese medicine, Fusen has established a 30000 acre high standard honeysuckle planting demonstration base, supported by the integration and innovation of authentic medicinal material production technology, effectively controlling the uniformity and safety of honeysuckle quality, and providing high-quality honeysuckle raw materials for the production of Fusen Shuanghuanglian oral liquid. After 50 years of sedimentation and 30 years of honing, since its launch in 1988, Fusen Shuanghuanglian has entered millions of stores and been exported to countries such as Brazil and Mozambique. It is a "nationally certified and reliable product with quality standards".

Fusen Shuanghuanglian Oral Liquid has been listed on the "2022-2023 Chinese Family Regular Medicines Top Brands" Cold Medicine List. This honor is a recognition of Fusen Pharmaceutical's continuous efforts and its continued development in the field of traditional Chinese medicine. In addition to Shuanghuanglian Oral Liquid, Fusen Pharmaceutical also has a series of other products in the treatment field, including heat clearing and detoxification, cardiovascular and cerebrovascular diseases, blood pressure lowering and sugar lowering, tonifying, qi regulating, anti anemia, antibacterial and anti-inflammatory, etc.

In the future, Fusen Pharmaceutical will continue to devote itself to the research and production of traditional Chinese medicine, continuously improving product quality and efficacy, and providing consumers with more high-quality health products. At the same time, we also look forward to Fusen Pharmaceuticals continuing to lead the development of the Chinese household standing medicine market, providing safe and effective drug choices for more families, assisting in the implementation of the Healthy China strategy, and injecting new vitality into the Healthy China action.